Condition
Idiopathic Interstitial Pneumonias
Total Trials
6
Recruiting
1
Active
1
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results33% success
Data Visualizations
Phase Distribution
2Total
Early P 1 (1)
P 2 (1)
Trial Status
Terminated2
Enrolling By Invitation1
Unknown1
Completed1
Recruiting1
Trial Success Rate
33.3%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03747627Completed
BPF Genetics of ILD Study
NCT05365802Early Phase 1Recruiting
FAPI PET for Lung Fibrosis
NCT04896138Enrolling By Invitation
University of Virginia Natural History Study
NCT03142191Phase 2Terminated
A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis
NCT04511884Unknown
Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid
NCT01151527TerminatedPrimary
Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias
Showing all 6 trials